TRI-CON 2022: Driving Innovation and Collaboration in Diagnostics and Precision Medicine

Over the past 28 years, the Tri-Conference has served as the leading international meeting place for the precision medicine community. As the world faces the challenges from the pandemic recovery, Cambridge Healthech Institute once again takes the leadership role of bringing together the life science community at the TRI-CON 2022. Join thousands of international thought leaders —in-person and/or virtually— to discuss the latest research and technologies in precision medicine and precision health; innovation in point-of-care and molecular diagnostics and market access strategies; advanced diagnostics for COVID-19 and other infectious diseases; precision oncology diagnostics and therapeutics; liquid biopsy and minimal residual disease testing; biomarkers and companion diagnostics; and new technologies for spatial multi-omic analysis. Come to sunny San Diego for the in-person networking you’ve come to expect from the Tri-Conference; or join us virtually from the comfort of your home or office for online networking, the cutting-edge scientific program, and convenient on-demand viewing.





2021 Keynote & Featured Speakers

Timothy Stenzel

Timothy Stenzel
Director, Office of In Vitro Diagnostics and Radiological Health
FDA

Hanneke Schuitemaker

Hanneke Schuitemaker
VP, Viral Vaccine Discovery & Translational Medicine
Janssen

Mene Pangalos

Mene Pangalos
EVP, Biopharmaceuticals R&D
AstraZeneca

Cecilia Schott

Cecilia Schott
Head, Global Precision Medicine Strategy
Novartis

Sanjay Gurunathan

Sanjay Gurunathan
VP, Head, Clinical Sciences
Sanofi

Karen Kaul

Karen Kaul
Chair, Pathology and Laboratory Medicine
NorthShore University HealthSystem

Steven Schachter

Steven Schachter
RADx Chief; Professor
Harvard Medical School

Esther Babady

Esther Babady
Head, Clinical Microbiology
Memorial Sloan Kettering Cancer Center

Robert Johnson

Robert Johnson
Director, Infectious Disease
BARDA

Hakan Sakul

Hakan Sakul
VP, Head, Diagnostics
Pfizer

Zhen Su

Zhen Su
Merck KGaA Darmstadt, Germany

Razelle Kurzrock

Razelle Kurzrock
Director, Personalized Cancer Therapy
UCSD

Charles Chiu

Charles Chiu
Director, UCSF-Abbott Viral Diagnostics and Discovery Center
UCSF

Peter Hotez

Peter Hotez
Dean, National School of Tropical Medicine
Baylor College of Medicine

Carolyn Compton

Carolyn Compton
CMO
National Biomarker Development Alliance

Kristin Blouch

Kristin Blouch
Director, Disease Characterization
GlaxoSmithKline

Michael Snyder

Michael Snyder
Director, Genomics & Personalized Medicine
Stanford

Mark T. Esser

Mark T. Esser
VP, Microbial Sciences
AstraZeneca

Dan Barouch

Dan Barouch
Director, Virology and Vaccine Research
Beth Israel Deaconess Medical Center

Tomas Cihlar

Tomas Cihlar
VP, Virology
Gilead

Sights and Scenes from previous TRI-CONs




Premier Sponsors






Key Contacts

Jon Stroup

For partnering & sponsorship, please contact:
Jon Stroup
Sr. Business Development Manager
Cambridge Healthtech Institute
781-972-5483 jstroup@healthtech.com

Julia Boguslavsky

For meeting questions or suggestions, please contact:
Julia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute
juliab@healthtech.com

Jennifer Salhus

For media and association partnerships, please contact:
Jennifer Salhus
Sr. Marketing Manager
Cambridge Healthtech Institute
781-972-5492
jsalhus@healthtech.com